Results of a global phase II study with crizotinib in advanced ALK-positive non-small-cell lung cancer (NSCLC) Meeting Abstract


Authors: Kim, D. W.; Ahn, M. J.; Shi, Y.; De Pas, T. M.; Yang, P. C.; Riely, G. J.; Crino, L.; Evans, T. L.; Liu, X.; Han, J. Y.; Salgia, R.; Lanzalone, S.; Polli, A.; Iyer, S.; Shaw, A. T.
Abstract Title: Results of a global phase II study with crizotinib in advanced ALK-positive non-small-cell lung cancer (NSCLC)
Meeting Title: 10th Annual Meeting of the Japanese Society of Medical Oncology
Journal Title: Annals of Oncology
Volume: 23
Issue: Suppl. 11
Meeting Dates: 2012 Jul 26-28
Meeting Location: Osaka, Japan
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2012-10-01
Start Page: xi32
End Page: xi33
Language: English
ACCESSION: WOS:000310634300082
PROVIDER: wos
DOI: 10.1093/annonc/mds554
Notes: Meeting Abstract: IS7-14 -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely